BCL-2, BAX and P53 expression profiles in endometrial carcinoma as studied by real-time PCR and immunohistochemistry

Anticancer Research

Volumn 29, Issue 10, 2009, Pages 3977-3982

  Porichi, Ourania ^a   Nikolaidou, Maria Evangelia ^a   Apostolaki, Aikaterini ^a   Tserkezoglou, Aliki ^a   Arnogiannaki, Niki ^a   Kassanos, Dimitrios ^b   Margaritis, Loukas ^b   Panotopoulou, Efstathia ^a  

^a Regional Anticancer Oncology Hospital of Athens 'St Savvas'   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Apoptosis; Bax; Bcl 2; Endometrium carcinoma; Immunohistochemistry; p53; Real time PCR

Indexed keywords

BETA ACTIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

BCL-2-ASSOCIATED X PROTEIN; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 71949110034     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Osford SM, Dallman CL, Johnson PW, Ganesan A and Packham G: Current strategies to target the anti-apoptotic bcl-2 protein in cancer cells. Curr Med Chem Apr 11(8): 1031-1039, 2004.
2. Hopwood D and Levison DA: Atrophy and apoptosis in the cyclical human endometrium. J Pathol 119: 159-166, 1976.
3. Tabibzaden S, Kong QF, Satyaswaroop PG, Zupi E, Marconi D, Romanini C and Kapur S: Distinct regional and menstrual cycle dependent distribution of apoptosis in human endometrium. Potential regulatory role of T-cells and TNF-alpha. Endocr J 2: 87-95, 1994.
4. Goumenou AG, Malliotakis IM, Tzardi M, Fragouli YG, Mahutte NG and Arici A: Apoptosis and differential expression of apoptosis-related proteins in endometriotic grandular and stromal cells. J Soc Gynecol Inestig Jul 11(5): 318-322, 2004. (Pubitemid 38833613)
5. Mertens HJ, Heineman MJ and Evers JL: The expression of apoptosis-related proteins bcl-2 and Ki67 in endometrium of ovulatory menstrual cycles. Gyn Obstet Invest 53(4): 224-230, 2002.
6. Maia H Jr, Maltez A, Studart E, Athayde C and Coutinho EM: Ki-67, bcl-2 and p53 expression in endometrial polyps and in normal endometrium during the menstrual cycle. Br J Obstet Gynaecol 111(11): 1242-1247, 2004. (Pubitemid 39472170)
7. Sakuragi N, Salah A, Watari H, Itoh T, Inoue S, Moriuchi T and Fujimoto S: Bax, bcl-2 and p53 expression in endometrial cancer. Gyn Oncol 86(3): 288-296, 2002. (Pubitemid 35425524)
8. Wang XW and Harris CC: P53 tumor-suppressor gene: clues to molecular carcinogenesis. J Cell Physiol 173(2): 247-255, 1997. (Pubitemid 27481139)
9. Cinel L, Polat A, Aydin O, Dusmez D and Egilmez R: Bcl-2, iNOS, p53 and PCNA expression in normal, disordered proliferative, hyperplastic and malignant endometrium. Pathol Int 52(5-6): 384-389, 2002. (Pubitemid 34748221)
10. Noyes RW and Herig AT: Dating the endometrial biopsy. Fertil Steril 1: 3-25, 1995.
11. Petterson F: Annual Report on the Results of Treatment in Gynecological Cancer. Stockholm, FIGO, 1988.
12. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment. Geneva, WHO, pp. 16-21, 1979.
13. Chomczynski P and Saccki N: Single-step method of RNA isolation by guanidium-thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987. (Pubitemid 17064313)
14. Mitselou A, Ioachim E, Kitsou E, Vougiouklakis T, Zagorianakou N, Makrydimas G, Stefanaki S and Agnantis NJ: Immunohistochemical study of apoptosis-related bcl-2 protein and its correlation with proliferation indices (Ki-67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features in normal, hyperplastic and neoplastic endometrium. In Vivo 17(5): 469-477, 2003. (Pubitemid 37328053)
15. Peiro G, Diebold J, Baretton G, Kimmig R and Lohrs U: Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with bcl-2, bax, caspase-3 expression and outcome. Int J Gynecol Pathol 20(4): 359-367, 2001. (Pubitemid 32937451)
16. Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H and Jones M: Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature. Mod Pathol 13(4): 379-388, 2000.
17. Vaskivuo TE, Stenback F and Tapanainen JS: Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha and NF-kappaB in human endometrial hyperplasia and carcinoma. Cancer Oct 1; 95(7): 1463-1467, 2002.
18. Bozdogan O, Atasoy P, Erekol S, Bozdogan N and Bayram M: Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic and neoplastic endometrium. Int J Gyn Pathol 21(4): 375-382, 2002. (Pubitemid 35052702)
19. Sari I, Gocmen A, Bitiren M and Cakmak EA: The relationship between expression of p53/bcl-2 and clinicopathological criteria in endometrioid adenocarcinomas of the endometrium. Eur J Gynecol Oncol 25(1): 79-80, 2004. (Pubitemid 38165925)
20. Kalogiannidis I, Bobos M, Papanikolaou A and Makedonas A.: Immunohistochemical bcl-2 expression, p53 overexpression, PR and ER status in endometrial carcinoma and survival outcomes, Eur J Gynaecol Oncol 29(1): 19-22, 2008.
21. Halperin R, Zehavi S, Habler L, Hadas E, Bukovsky I and Schneider D: Comparative immunohistochemical study of endometriod and serous papillary carcinoma of endometrium. Eur J Gynaecol Oncol 22(2): 122-126, 2001. (Pubitemid 32963063)
22. Mazurek A, Pierzynski P, Niklinska W, Chyczewski L and Laudanski T: Angiogenesis and bcl-2 protein expression in patients with endometrial carcinoma, Neoplasma 49(3): 149-154, 2002. (Pubitemid 34728791)
23. Erdem O, Erdem M, Dursum A, Akyol G and Erdem A: Angiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer: comparison with traditional clinicopathologic variables. Int J Gynecol Pathol 22(3): 254-260, 2003. (Pubitemid 36750407)
24. S expression in neoplastic and normal endometrium. Oncology 58: 161-168, 2000. (Pubitemid 30113868)
25. Lax SF: Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Vir Arch Mar 444(3): 213-223, 2004.
26. Erkanli S, Eren F, Pekin S and Bagis T: Bcl-2 and p53 expression in endometrial carcinoma, J Exp Clin Cancer Res Mar 23(1): 97-103, 2004. (Pubitemid 38552604)
27. Lomo L, Nicci MR, Lee KR, Li MC, Hirsch MS, Crum CP and Mutter GL: Histologic and immunohistochemical decision-making in endometrial adenocarcinoma, Mod Pathol 21(8): 937-942, 2008.
28. Utsunomiya H, Suzuki T, Ho K, Moriya T, Konno R, Sato S, Yaegashi N, Okamura K and Sasano H: The correlation between the response to progesterone treatment and the expression of progesterone receptor B and 17β-hydroxy- steroid dehydrogenase type 2 in human endometrial carcinoma. Clin Endoc 58: 696-700, 2003.